Vinge advised Impilo on the deal. Impilo secured the establishment of Impilo Orphan Drugs, a so-called continuation fund. The continuation fund will have EUR 320 million...
Impilo’s Establishment of a Continuation Fund
Zellis Group’s Acquisition of Benify
Vinge advised Zellis Group on the deal. Zellis Group finalized the acquisition of Benify, a provider of employee benefits administration software, from Vitruvian Partners and the...
CVC Capital Partners’ Acquisition of a Stake in Odevo
Vinge advised Fidelio Capital on the deal. Fidelio Capital and the other shareholders of Odevo Group secured the divestment of a minority shareholding to funds controlled...
Priveq’s Formation of Priveq Investment VII
Vinge assisted Priveq on the deal. Priveq, a leading Nordic lower mid-market growth and buyout investor, has closed its seventh fund, Priveq Investment VII, at SEK...
Alder’s Establishment of Alder III
Vinge advised Alder on the deal. Alder has successfully raised approximately SEK 3.1 billion in investment commitments from an international investor base, doubling the total investor...
Adelis Equity Partners’ Establishment of a Continuation Fund
Vinge advised Adelis Equity Partners on the deal. Adelis Equity Partners established a continuation fund to Adelis Equity Partners Fund II. The continuation fund is a so-called...
Carnegie’s Acquisition of Erik Penser Bank’s Securities Business
Vinge advised Carnegie Investment Bank AB on the deal. Carnegie Investment Bank AB completed the acquisition of the business sectors Erik Penser Wealth Management and Erik Penser...